The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Whole-Body Irradiation

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Whole-Body Irradiation

 

Psychiatry related information on Whole-Body Irradiation

 

High impact information on Whole-Body Irradiation

 

Chemical compound and disease context of Whole-Body Irradiation

 

Biological context of Whole-Body Irradiation

 

Anatomical context of Whole-Body Irradiation

 

Associations of Whole-Body Irradiation with chemical compounds

 

Gene context of Whole-Body Irradiation

 

Analytical, diagnostic and therapeutic context of Whole-Body Irradiation

References

  1. Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow. Phillips, G.L., Herzig, R.H., Lazarus, H.M., Fay, J.W., Wolff, S.N., Mill, W.B., Lin, H., Thomas, P.R., Glasgow, G.P., Shina, D.C. N. Engl. J. Med. (1984) [Pubmed]
  2. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. Storb, R., Deeg, H.J., Whitehead, J., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C.D., Clift, R., Doney, K., Farewell, V. N. Engl. J. Med. (1986) [Pubmed]
  3. Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms. Sullivan, K.M., Storb, R., Buckner, C.D., Fefer, A., Fisher, L., Weiden, P.L., Witherspoon, R.P., Appelbaum, F.R., Banaji, M., Hansen, J. N. Engl. J. Med. (1989) [Pubmed]
  4. Radiopharmaceutical therapy of 5T33 murine myeloma by sequential treatment with samarium-153 ethylenediaminetetramethylene phosphonate, melphalan, and bone marrow transplantation. Turner, J.H., Claringbold, P.G., Manning, L.S., O'Donoghue, H.L., Berger, J.D., Glancy, R.J. J. Natl. Cancer Inst. (1993) [Pubmed]
  5. Studies on the antitumor activities of pyrimidinone-interferon inducers. I. Effect against artificial and spontaneous lung metastases of murine tumors. Milas, L., Hersh, E.M., Stringfellow, D.A., Hunter, N. J. Natl. Cancer Inst. (1982) [Pubmed]
  6. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. McSweeney, P.A., Nash, R.A., Sullivan, K.M., Storek, J., Crofford, L.J., Dansey, R., Mayes, M.D., McDonagh, K.T., Nelson, J.L., Gooley, T.A., Holmberg, L.A., Chen, C.S., Wener, M.H., Ryan, K., Sunderhaus, J., Russell, K., Rambharose, J., Storb, R., Furst, D.E. Blood (2002) [Pubmed]
  7. Effects of methotrexate and total body irradiation on mouse lungs. Alam, M.I., Jafarey, N.A. JPMA. The Journal of the Pakistan Medical Association. (1990) [Pubmed]
  8. Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Wu, W.S., Heinrichs, S., Xu, D., Garrison, S.P., Zambetti, G.P., Adams, J.M., Look, A.T. Cell (2005) [Pubmed]
  9. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. Parkman, R., Rappeport, J., Geha, R., Belli, J., Cassady, R., Levey, R., Nathan, D.G., Rosen, F.S. N. Engl. J. Med. (1978) [Pubmed]
  10. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. Wekerle, T., Sayegh, M.H., Hill, J., Zhao, Y., Chandraker, A., Swenson, K.G., Zhao, G., Sykes, M. J. Exp. Med. (1998) [Pubmed]
  11. Antitumor activity of recombinant interleukin 6 in mice. Mulé, J.J., McIntosh, J.K., Jablons, D.M., Rosenberg, S.A. J. Exp. Med. (1990) [Pubmed]
  12. Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2. Rosenberg, S.A., Mulé, J.J., Spiess, P.J., Reichert, C.M., Schwarz, S.L. J. Exp. Med. (1985) [Pubmed]
  13. Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells. Reiffers, J., Cailliot, C., Dazey, B., Attal, M., Caraux, J., Boiron, J.M. Lancet (1999) [Pubmed]
  14. Host conditioning with 5-fluorouracil and kit-ligand to provide for long-term bone marrow engraftment. van Os, R., Dawes, D., Mislow, J.M., Witsell, A., Mauch, P.M. Blood (1997) [Pubmed]
  15. Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma. Maris, M.B., Sandmaier, B.M., Storer, B.E., Chauncey, T., Stuart, M.J., Maziarz, R.T., Agura, E., Langston, A.A., Pulsipher, M., Storb, R., Maloney, D.G. Blood (2004) [Pubmed]
  16. High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission. Coccia, P.F., Strandjord, S.E., Warkentin, P.I., Cheung, N.K., Gordon, E.M., Novak, L.J., Shina, D.C., Herzig, R.H. Blood (1988) [Pubmed]
  17. Allogeneic bone marrow transplantation for low-grade lymphoma. van Besien, K., Sobocinski, K.A., Rowlings, P.A., Murphy, S.C., Armitage, J.O., Bishop, M.R., Chaekal, O.K., Gale, R.P., Klein, J.P., Lazarus, H.M., McCarthy, P.L., Raemaekers, J.M., Reiffers, J., Phillips, G.L., Schattenberg, A.V., Verdonck, L.F., Vose, J.M., Horowitz, M.M. Blood (1998) [Pubmed]
  18. Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide. Girgis, M., Hallemeier, C., Blum, W., Brown, R., Lin, H.S., Khoury, H., Goodnough, L.T., Vij, R., Devine, S., Wehde, M., Postma, S., Oza, A., Dipersio, J., Adkins, D. Blood (2005) [Pubmed]
  19. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Baron, F., Baker, J.E., Storb, R., Gooley, T.A., Sandmaier, B.M., Maris, M.B., Maloney, D.G., Heimfeld, S., Oparin, D., Zellmer, E., Radich, J.P., Grumet, F.C., Blume, K.G., Chauncey, T.R., Little, M.T. Blood (2004) [Pubmed]
  20. Anemia and mast cell depletion in mutant rats that are homozygous at "white spotting (Ws)" locus. Niwa, Y., Kasugai, T., Ohno, K., Morimoto, M., Yamazaki, M., Dohmae, K., Nishimune, Y., Kondo, K., Kitamura, Y. Blood (1991) [Pubmed]
  21. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin. Kirichenko, A.V., Rich, T.A., Newman, R.A., Travis, E.L. Cancer Res. (1997) [Pubmed]
  22. Dependence of indomethacin-induced potentiation of murine tumor radioresponse on tumor host immunocompetence. Milas, L., Furuta, Y., Hunter, N., Nishiguchi, I., Runkel, S. Cancer Res. (1990) [Pubmed]
  23. Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. Takvorian, T., Canellos, G.P., Ritz, J., Freedman, A.S., Anderson, K.C., Mauch, P., Tarbell, N., Coral, F., Daley, H., Yeap, B. N. Engl. J. Med. (1987) [Pubmed]
  24. Heterogeneity of natural killer cells in the mouse. Lust, J.A., Kumar, V., Burton, R.C., Bartlett, S.P., Bennett, M. J. Exp. Med. (1981) [Pubmed]
  25. Neoplastic and life-span effects of chronic exposure to tritium. I. Effects on adult rats exposed during pregnancy. Cahill, D.F., Wright, J.F., Godbold, J.H., Ward, J.M., Laskey, J.W., Tompkins, E.A. J. Natl. Cancer Inst. (1975) [Pubmed]
  26. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation. Burt, R.K., Traynor, A.E., Pope, R., Schroeder, J., Cohen, B., Karlin, K.H., Lobeck, L., Goolsby, C., Rowlings, P., Davis, F.A., Stefoski, D., Terry, C., Keever-Taylor, C., Rosen, S., Vesole, D., Fishman, M., Brush, M., Mujias, S., Villa, M., Burns, W.H. Blood (1998) [Pubmed]
  27. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Taylor, P.A., Lees, C.J., Blazar, B.R. Blood (2002) [Pubmed]
  28. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. Anasetti, C., Amos, D., Beatty, P.G., Appelbaum, F.R., Bensinger, W., Buckner, C.D., Clift, R., Doney, K., Martin, P.J., Mickelson, E. N. Engl. J. Med. (1989) [Pubmed]
  29. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. Yeager, A.M., Kaizer, H., Santos, G.W., Saral, R., Colvin, O.M., Stuart, R.K., Braine, H.G., Burke, P.J., Ambinder, R.F., Burns, W.H. N. Engl. J. Med. (1986) [Pubmed]
  30. Bone-marrow transplant from father to son and subsequent graft from son to father. Powles, R.L., Parikh, P.M., Helenglass, G., Aboud, H.H., Smith, C.L., Mrazek, I.A., Shepherd, V., Milliken, S.T., Treleaven, J., Sharrock, C. Lancet (1990) [Pubmed]
  31. Factors associated with interstitial pneumonitis after bone-marrow transplantation for acute leukaemia. Bortin, M.M., Kay, H.E., Gale, R.P., Rimm, A.A. Lancet (1982) [Pubmed]
  32. Autologous bone-marrow transplantation in relapsed adult acute leukaemia. Dicke, K.A., Zander, A., Spitzer, G., Verma, D.S., Peters, L., Vellekoop, L., McCredie, K.B., Hester, J. Lancet (1979) [Pubmed]
  33. Single administration of thrombopoietin to lethally irradiated mice prevents infectious and thrombotic events leading to mortality. Mouthon, M.A., Gaugler, M.H., Van der Meeren, A., Vandamme, M., Gourmelon, P., Wagemaker, G. Exp. Hematol. (2001) [Pubmed]
  34. Differential role of Stat5 isoforms in effecting hematopoietic recovery induced by Mpl-ligand in lethally myelosuppressed mice. Pestina, T.I., Jackson, C.W. Exp. Hematol. (2003) [Pubmed]
  35. Characterization of the acute inflammatory response after irradiation in mice and its regulation by interleukin 4 (Il4). Van der Meeren, A., Monti, P., Lebaron-Jacobs, L., Marquette, C., Gourmelon, P. Radiat. Res. (2001) [Pubmed]
  36. A phase II trial of low-dose total body irradiation and subcutaneous interleukin-2 in metastatic melanoma. Safwat, A., Schmidt, H., Bastholt, L., Fode, K., Larsen, S., Aggerholm, N., von der Maase, H. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. (2005) [Pubmed]
  37. IL-6 a key cytokine in in vitro and in vivo response of Sertoli cells to external gamma irradiation. Legué, F., Guitton, N., Brouazin-Jousseaume, V., Colleu-Durel, S., Nourgalieva, K., Chenal, C. Cytokine (2001) [Pubmed]
  38. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group Trial. Lazarus, H.M., Andersen, J., Chen, M.G., Variakojis, D., Mansour, E.G., Oette, D., Arce, C.A., Oken, M.M., Gerson, S.L. Blood (1991) [Pubmed]
  39. Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial. Moreau, P., Facon, T., Attal, M., Hulin, C., Michallet, M., Maloisel, F., Sotto, J.J., Guilhot, F., Marit, G., Doyen, C., Jaubert, J., Fuzibet, J.G., François, S., Benboubker, L., Monconduit, M., Voillat, L., Macro, M., Berthou, C., Dorvaux, V., Pignon, B., Rio, B., Matthes, T., Casassus, P., Caillot, D., Najman, N., Grosbois, B., Bataille, R., Harousseau, J.L. Blood (2002) [Pubmed]
  40. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Bensinger, W.I., Weaver, C.H., Appelbaum, F.R., Rowley, S., Demirer, T., Sanders, J., Storb, R., Buckner, C.D. Blood (1995) [Pubmed]
  41. A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas. Press, O.W., Eary, J.F., Gooley, T., Gopal, A.K., Liu, S., Rajendran, J.G., Maloney, D.G., Petersdorf, S., Bush, S.A., Durack, L.D., Martin, P.J., Fisher, D.R., Wood, B., Borrow, J.W., Porter, B., Smith, J.P., Matthews, D.C., Appelbaum, F.R., Bernstein, I.D. Blood (2000) [Pubmed]
 
WikiGenes - Universities